Nepsis Inc’s Johnson & Johnson JNJ Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-94,107
| Closed | -$15.6M | – | 29 |
|
|
2023
Q2 | $15.6M | Sell |
94,107
-692
| -0.7% | -$112K | 4.8% | 6 |
|
|
2023
Q1 | $14.7M | Buy |
94,799
+8,662
| +10% | +$1.4M | 4.89% | 7 |
|
|
2022
Q4 | $15.2M | Sell |
86,137
-405
| -0.5% | -$69.9K | 5.09% | 6 |
|
|
2022
Q3 | $14.1M | Buy |
86,542
+18,917
| +28% | +$3.2M | 5.11% | 4 |
|
|
2022
Q2 | $12M | Buy |
+67,625
| New | +$12M | 4.09% | 11 |
|
|
2020
Q1 | – | Sell |
-38,736
| Closed | -$5.62M | – | 38 |
|
|
2019
Q4 | $5.62M | Buy |
38,736
+2,554
| +7% | +$346K | 2.85% | 21 |
|
|
2019
Q3 | $4.75M | Sell |
36,182
-1,880
| -5% | -$248K | 2.74% | 19 |
|
|
2019
Q2 | $5.3M | Sell |
38,062
-3,479
| -8% | -$482K | 2.94% | 18 |
|
|
2019
Q1 | $5.81M | Sell |
41,541
-796
| -2% | -$107K | 3.03% | 17 |
|
|
2018
Q4 | $5.46M | Buy |
42,337
+941
| +2% | +$131K | 3.62% | 13 |
|
|
2018
Q3 | $5.72M | Sell |
41,396
-684
| -2% | -$90.9K | 3.16% | 18 |
|
|
2018
Q2 | $5.11M | Buy |
42,080
+3,426
| +9% | +$427K | 2.55% | 21 |
|
|
2018
Q1 | $4.95M | Sell |
38,654
-10,330
| -21% | -$1.4M | 2.62% | 20 |
|
|
2017
Q4 | $6.84M | Sell |
48,984
-219
| -0.4% | -$30.5K | 3.47% | 13 |
|
|
2017
Q3 | $6.4M | Sell |
49,203
-5,336
| -10% | -$707K | 3.3% | 12 |
|
|
2017
Q2 | $7.21M | Sell |
54,539
-893
| -2% | -$114K | 3.56% | 5 |
|
|
2017
Q1 | $6.9M | Sell |
55,432
-11,391
| -17% | -$1.36M | 3.54% | 6 |
|
|
2016
Q4 | $7.7M | Buy |
66,823
+2,999
| +5% | +$346K | 4.41% | 4 |
|
|
2016
Q3 | $7.54M | Sell |
63,824
-5,442
| -8% | -$660K | 4.11% | 4 |
|
|
2016
Q2 | $8.4M | Sell |
69,266
-10,512
| -13% | -$1.19M | 4.79% | 1 |
|
|
2016
Q1 | $8.63M | Sell |
79,778
-21,534
| -21% | -$2.23M | 4.63% | 1 |
|
|
2015
Q4 | $10.4M | Sell |
101,312
-10,720
| -10% | -$1.08M | 6.04% | 2 |
|
|
2015
Q3 | $10.5M | Buy |
112,032
+2,542
| +2% | +$246K | 6.23% | 1 |
|
|
2015
Q2 | $10.8M | Buy |
109,490
+1,806
| +2% | +$181K | 7.26% | 1 |
|
|
2015
Q1 | $10.8M | Buy |
107,684
+8,387
| +8% | +$853K | 6.54% | 1 |
|
|
2014
Q4 | $10.4M | Buy |
99,297
+1,239
| +1% | +$131K | 6.06% | 2 |
|
|
2014
Q3 | $5.6M | Buy |
98,058
+3,303
| +3% | +$343K | 3.2% | 6 |
|
|
2014
Q2 | $10M | Sell |
94,755
-1,870
| -2% | -$189K | 5.52% | 1 |
|
|
2014
Q1 | $9.46M | Buy |
96,625
+11,419
| +13% | +$1.06M | 5.75% | 2 |
|
|
2013
Q4 | $7.8M | Buy |
+85,206
| New | +$7.85M | 5.39% | 3 |
|
Other funds holding JNJ
Nepsis Inc's JNJ Position: Q3 2023 in Review
Nepsis Inc sold out of Johnson & Johnson (JNJ) in Q3 2023, closing a stake of 94,107 shares — an estimated $15.6M sold.
Nepsis Inc first reported a position in JNJ in Q4 2013 and held it in 30 quarters. The position peaked at $15.6M in Q2 2023. 3,679 funds tracked by Wall St. Rank hold JNJ as of Q3 2023.
- Nepsis Inc reported no remaining Johnson & Johnson position as of Q3 2023 after selling out during the quarter.
- Nepsis Inc sold 94,107 Johnson & Johnson shares in Q3 2023, an estimated $15.6M.
- Nepsis Inc first reported a position in Johnson & Johnson in Q4 2013 and held it in 30 quarters.
- Nepsis Inc's Johnson & Johnson position peaked at $15.6M in Q2 2023.
- 3,679 funds tracked by Wall St. Rank held Johnson & Johnson as of Q3 2023.
Based on Nepsis Inc's 13F filing for Q3 2023, filed 13 Oct 2023.